These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 19285385

  • 1. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer.
    Choe YH, Kim SR, Lee KS, Lee KY, Park SJ, Jin GY, Lee YC.
    Eur J Cancer; 2009 Jul; 45(10):1773-9. PubMed ID: 19285385
    [Abstract] [Full Text] [Related]

  • 2. Percutaneous thermal ablation of primary lung cancer.
    de Baere T, Tselikas L, Catena V, Buy X, Deschamps F, Palussière J.
    Diagn Interv Imaging; 2016 Oct; 97(10):1019-1024. PubMed ID: 27692673
    [Abstract] [Full Text] [Related]

  • 3. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer.
    Kim SR, Han HJ, Park SJ, Min KH, Lee MH, Chung CR, Kim MH, Jin GY, Lee YC.
    Eur J Radiol; 2012 Feb; 81(2):395-9. PubMed ID: 21310562
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors.
    Thanos L, Mylona S, Pomoni M, Athanassiadi K, Theakos N, Zoganas L, Batakis N.
    Eur J Cardiothorac Surg; 2006 Nov; 30(5):797-800. PubMed ID: 17000115
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous CT-guided radiofrequency ablation as supplemental therapy after systemic chemotherapy for selected advanced non-small cell lung cancers.
    Li X, Zhao M, Wang J, Fan W, Li W, Pan T, Wu P.
    AJR Am J Roentgenol; 2013 Dec; 201(6):1362-7. PubMed ID: 24261378
    [Abstract] [Full Text] [Related]

  • 6. Bronchoscopy-Guided Cooled Radiofrequency Ablation as a Novel Intervention Therapy for Peripheral Lung Cancer.
    Koizumi T, Tsushima K, Tanabe T, Agatsuma T, Yokoyama T, Ito M, Kanda S, Kobayashi T, Yasuo M.
    Respiration; 2015 Dec; 90(1):47-55. PubMed ID: 26044954
    [Abstract] [Full Text] [Related]

  • 7. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
    Bilal H, Mahmood S, Rajashanker B, Shah R.
    Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?
    Yoo DC, Dupuy DE, Hillman SL, Fernando HC, Rilling WS, Shepard JA, Siegel BA.
    AJR Am J Roentgenol; 2011 Aug; 197(2):334-40. PubMed ID: 21785078
    [Abstract] [Full Text] [Related]

  • 13. [Radiofrequency ablation of malignant lung tumours. Judicious approach?].
    Jungraithmayr W, Schäfer O, Stoelben E, Hasse J, Passlick B.
    Chirurg; 2005 Sep; 76(9):887-93. PubMed ID: 15864704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Radiofrequency thermal ablation in the treatment of lung malignancies.
    Gadaleta C, Catino A, Mattioli V.
    In Vivo; 2006 Sep; 20(6A):765-7. PubMed ID: 17203764
    [Abstract] [Full Text] [Related]

  • 16. High-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary study.
    Liu H, Steinke K.
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):466-74. PubMed ID: 23870347
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.